Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02865447 · ClinicalTrials.gov registry record
Evaluation of Bone Mineral Density Changes After Total Hip Replacement: A Two-Year Clinical and DXA Analysis
A clinical trial, sponsored by MicroPort Orthopedics.
- Completed
- Registry status
- 25
- Enrollment target
NCT02865447 is a clinical trial that has completed, run by MicroPort Orthopedics. The registered enrollment target is 25 participants.
The verdict
NCT02865447 has completed, sponsored by MicroPort Orthopedics.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Sponsor is conducting this post-market study to evaluate the clinical outcome and femoral bone mineral density (BMD) changes associated with the PROFEMUR® PRESERVE hip stem when used as indicated for primary total hip arthroplasty in patients with osteoarthritis of the hip joint.
Interventions
- DEVICE total hip arthroplasty implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-03-09 |
| Est. Completion | 2020-08-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02865447
The ClinicalTrials.gov registry entry for NCT02865447 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MicroPort Orthopedics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which total hip arthroplasty implant is the first listed.
NCT02865447 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02865447 about?
NCT02865447 is a clinical study titled "Evaluation of Bone Mineral Density Changes After Total Hip Replacement: A Two-Year Clinical and DXA Analysis". Sponsor is conducting this post-market study to evaluate the clinical outcome and femoral bone mineral density (BMD) changes associated with the PROFEMUR® PRESERVE hip stem when used as indicated for primary total hip arthroplasty in patients with osteoarthritis of the hip joint.
What is the current status of trial NCT02865447?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2017-03-09. Estimated completion is 2020-08-24.
What interventions are being tested in trial NCT02865447?
The interventions under investigation include: total hip arthroplasty implant (DEVICE).
Who is sponsoring clinical trial NCT02865447?
This trial is sponsored by MicroPort Orthopedics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.